These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1205 related items for PubMed ID: 10941557
1. Malignant melanoma, dysplastic melanocytic nevi, and Spitz tumors. Histologic classification and characteristics. Barnhill RL. Clin Plast Surg; 2000 Jul; 27(3):331-60, viii. PubMed ID: 10941557 [Abstract] [Full Text] [Related]
2. [Intra-epithelial melanocytic neoplasia (MIN), a new term proposed for dysplastic melanocytic lesions]. Collina G. Pathologica; 1997 Apr; 89(2):196-8. PubMed ID: 9411373 [No Abstract] [Full Text] [Related]
3. Mythology and numerology in the sphere of melanoma. Ackerman AB. Cancer; 2000 Feb 01; 88(3):491-6. PubMed ID: 10649238 [No Abstract] [Full Text] [Related]
4. Current diagnostic problems in melanoma pathology. Ruiter DJ, van Dijk MC, Ferrier CM. Semin Cutan Med Surg; 2003 Mar 01; 22(1):33-41. PubMed ID: 12773012 [Abstract] [Full Text] [Related]
5. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ. Khalifeh I, Taraif S, Reed JA, Lazar AF, Diwan AH, Prieto VG. Am J Surg Pathol; 2007 Jul 01; 31(7):1130-6. PubMed ID: 17592281 [Abstract] [Full Text] [Related]
6. Melanocytic nevi with features of Spitz nevi and Clark's/dysplastic nevi ("Spark's" nevi). Ko CJ, McNiff JM, Glusac EJ. J Cutan Pathol; 2009 Oct 01; 36(10):1063-8. PubMed ID: 19187111 [Abstract] [Full Text] [Related]
7. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging. Pilch H, Günzel S, Schäffer U, Tanner B, Heine M. Cancer; 2000 Mar 15; 88(6):1370-7. PubMed ID: 10717619 [Abstract] [Full Text] [Related]
8. Spitz nevi: In vivo confocal microscopic features, dermatoscopic aspects, histopathologic correlates, and diagnostic significance. Pellacani G, Longo C, Ferrara G, Cesinaro AM, Bassoli S, Guitera P, Menzies SW, Seidenari S. J Am Acad Dermatol; 2009 Feb 15; 60(2):236-47. PubMed ID: 19091443 [Abstract] [Full Text] [Related]
9. Dysplastic melanocytic nevi and prognostically indeterminate nevomelanomatoid proliferations. Kim JC, Murphy GF. Clin Lab Med; 2000 Dec 15; 20(4):691-712. PubMed ID: 11221510 [Abstract] [Full Text] [Related]
10. Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas? Kaleem Z, Lind AC, Humphrey PA, Sueper RH, Swanson PE, Ritter JH, Wick MR. Mod Pathol; 2000 Mar 15; 13(3):217-22. PubMed ID: 10757331 [Abstract] [Full Text] [Related]
12. hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue. Fullen DR, Zhu W, Thomas D, Su LD. J Cutan Pathol; 2005 Nov 15; 32(10):680-4. PubMed ID: 16293180 [Abstract] [Full Text] [Related]
15. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions. Nasr MR, El-Zammar O. Am J Dermatopathol; 2008 Apr 15; 30(2):117-22. PubMed ID: 18360113 [Abstract] [Full Text] [Related]